Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Banks, insurance dodge carnage as real estate stocks sink

Thu, 03rd Nov 2022 09:28

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

BANKS, INSURANCE DODGE CARNAGE AS REAL ESTATE STOCKS SINK (0818 GMT)

Europe's STOXX 600 is flashing red as signalled by earlier futures trading, last down 0.9% after U.S. markets took a battering on Wednesday.

Only two sectors are spared from the carnage; banks are up 0.3%, and insurance is up 0.2%.

The former is helped out by the Netherlands' largest bank ING Groep which has rallied 5.5% after reporting Q3 results and rolling out a share buyback plan worth 1.5 billion euros ($1.46 billion).

A 2.7% lift for BNP Paribas after Q3 profits topped forecasts can't hurt either.

The two banks are also helping to stem losses on the STOXX 600 and are the two biggest positive weights in the index. Meanwhile, insurer AXA is up 1.7%.

But the share price outperformer is Denmark-based IT consultancy company Netcompany , with shares rising 20.5% after some upbeat Q3 financials.

The UK's Hikma Pharmaceuticals, up 5.5%, is also helping lift the index after reiterating 2022 guidance in a trading statement.

Real estate stocks are down 2.5%, and in what is a familiar story in recent months. They're also the worst performing sector , followed closely by autos travel and tech, all down about 2%.

Dutch semiconductor maker ASML is providing the biggest drag on the broader STOXX 600, down 3.3%, as are Danish healthcare company Novo Nordisk and France's LVMH , down 1.6% and 1.7% respectively.

Thyssenkrupp shares are down 8.9% after Deutsche Bank cut the German submarine-to-steel group to "hold" from "buy", citing macroeconomic difficulties and an overly complex group structure.

ONE CENTRAL BANK DRAMA AFTER ANOTHER (0745 GMT)

So, Jerome Powell found a way to quiet the endless market chatter of a pivot even as he opened the door to smaller hikes.

Clearly the Fed chief doesn't want the bond market to rally so much that it eases U.S. financial conditions while inflation is still running hot. Ironically, the more bonds price in a pivot, the less inclined the Fed will be to give them one.

As a result, May Fed funds have shifted to 5.08% from 4.90% at end of last week, and there's less chance of a cut priced in by late next year. The yield curve bear-flattened and has not been this inverted since the turn of the century.

Now it's time for the Old Lady of Threadneedle Street to enter stage right and do her routine for the cameras. The Monetary Policy Report is out at noon (1200 GMT), followed by a news conference half an hour later streamed live on the Bank of England's website.

Markets are priced for a hike of 75 bps to 3.0%, which amazingly would be the highest since 2008. What happened to the goode olde days of 10%-plus?

Some are tipping 50 bps, but that would risk markets concluding the BoE isn't serious about taming inflation and spooking gilts again. Equally, 100 bps would just fan fears of a much deeper recession and an even bigger budget black hole.

In any event, the BoE is going to have to revise up its CPI forecasts and slash those for GDP, which will make for gloomy viewing compared to the comedy show that is government policy right now.

Other key developments that could influence markets on Thursday:

U.S. initial jobless claims seen at 220K

ISM service sector PMI is forecast at 55.5

Earnings include ConocoPhillips, Kellogg, Starbucks

STOXX POISED TO FALL AS MARKET DIGESTS FED, TURNS TO BOE (0739 GMT)

European stocks are set for a fall of 1.1% at the open, as the market continues to digest the "double-sided message" delivered by the Fed on Wednesday which saw U.S stocks shed 2.5% into the close after initially rising following an expected 75-bps rate hike.

Attention turns to the Bank of England's midday rate announcement. Market expectations centre on a similar hike of 75 bps - which would be the central bank's largest since 1989 as it battles the highest inflation in 40 years.

Earnings season continues, with euro zone's biggest lender BNP Paribas posting a higher-than-expected net profit in the third quarter.

German premium carmaker BMW has reported better than expected quarterly net profit - thanks to high car prices - but warned that rising inflation and interest rates would start to weigh on sales in the coming months.

Higher costs for energy and raw materials, as well as a weakening building materials market are behind a potential 10% drop in 2022 operating profit for the world's No. 2 cement maker Heidelberg Materials.

Meanwhile one of the biggest net losses in German corporate history of 40 billion euro ($39.3 billion has been unveiled by soon-to-be-nationalised gas importer Uniper.

More News
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more
27 Sep 2021 09:31

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual

Read more
27 Sep 2021 09:28

UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...

Read more
27 Sep 2021 08:50

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win

Read more
27 Sep 2021 08:16

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million

Read more
27 Sep 2021 07:49

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
27 Sep 2021 07:05

Hikma buys Custopharm for $375m

(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.

Read more
13 Sep 2021 16:09

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
2 Sep 2021 09:38

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.